AGM/EGMJul 16, 2026, 07:36 AM
Quoin Pharmaceuticals Schedules 2026 Annual General Meeting
AI Summary
Quoin Pharmaceuticals, Ltd. announced its 2026 Annual General Meeting of Shareholders (AGM) to be held on August 20, 2026. Shareholders will vote on several key proposals, including the election of seven directors, an advisory vote on executive compensation, and changes to non-employee director compensation and 401(k) matching contributions. Additionally, the appointment of CBIZ CPAs P.C. as the independent auditor will be considered. The record date for voting eligibility is July 15, 2026.
Key Highlights
- Quoin Pharmaceuticals will hold its 2026 Annual General Meeting on August 20, 2026, at 12:00 p.m. US Eastern Time.
- The meeting will take place at the offices of Blank Rome LLP in Philadelphia, PA.
- Shareholders will vote on the election of 7 directors.
- Proposals include an advisory vote on named executive officer compensation.
- Shareholders will also vote on changes to non-employee directors' compensation program.
- Approval of changes to 401(k) plan matching contributions is also on the agenda.
- CBIZ CPAs P.C. is proposed for appointment as the independent registered public accounting firm.
- The record date for shareholders entitled to vote is July 15, 2026.
Price Impact
More from QNRX